United Health Products, INC. (UEEC) — SEC Filings

Overview

United Health Products, INC. (UEEC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Apr 15, 2026: United Health Products, Inc. filed its annual report on Form 10-K for the period ending December 31, 2025, on April 15, 2026. The filing includes the main 10-K document, XBRL data, and various certifications. The company is based in Mesquite, NV, and operates in the Orthopedic, Prosthetic & Surgical

Sentiment Summary

Across 19 filings, the sentiment breakdown is: 2 bearish, 17 neutral. The dominant filing sentiment for United Health Products, INC. is neutral.

Filing Type Overview

United Health Products, INC. (UEEC) has filed 3 10-K, 5 8-K, 6 10-Q, 1 SC 13D/A, 3 S-1/A, 1 S-1 with the SEC between Apr 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (19)

• United Health Products Files 2025 10-K — 10-K · Apr 15, 2026 Risk: low
  United Health Products, Inc. filed its annual report on Form 10-K for the period ending December 31, 2025, on April 15, 2026. The filing includes the main 10-K
• United Health Products Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 22, 2025 Risk: medium
  On December 16, 2025, United Health Products, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also report
• UEEC's Losses Mount Amid Zero Revenue, Cash Dwindles — 10-Q · Nov 14, 2025 Risk: high
  United Health Products, Inc. (UEEC) reported no revenue for the three and nine months ended September 30, 2025, consistent with the prior year. The company expe
• UEEC's Net Loss Doubles Amid Zero Revenue, Cash Dries Up — 10-Q · Aug 14, 2025 Risk: high
  United Health Products, Inc. (UEEC) reported no revenue for the three and six months ended June 30, 2025, continuing its pre-revenue status. The company's net l
• United Health Products Announces Board and Officer Changes — 8-K · Jun 16, 2025 Risk: medium
  United Health Products, Inc. announced on June 12, 2025, a series of corporate actions including the departure of a director, the election of new directors, and
• United Health Products Files 8-K — 8-K · May 8, 2025 Risk: low
  United Health Products, Inc. filed an 8-K on May 8, 2025, reporting other events and financial statements/exhibits as of May 1, 2025. The company, formerly know
• United Health Products Q1 2025: Minimal Revenue, High Assets — 10-Q · May 5, 2025 Risk: high
  United Health Products, Inc. filed a 10-Q for the period ending March 31, 2025. The company reported $0.001 in revenue for Q1 2025, with total assets valued at
• United Health Products Files 2024 10-K — 10-K · Mar 28, 2025 Risk: low
  United Health Products, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, previously known as United EcoEnergy Corp., is involved i
• Beplate Amends Ownership Filing for United Health Products — SC 13D/A · Dec 4, 2024 Risk: medium
  Douglas K. Beplate filed an amendment (No. 1) to Schedule 13D on December 3, 2024, for United Health Products, Inc. This filing indicates a change in beneficial
• United Health Products, Inc. Files Q3 2024 10-Q — 10-Q · Nov 12, 2024 Risk: medium
  United Health Products, Inc. filed its 10-Q for the period ending September 30, 2024. The company, previously known as United EcoEnergy Corp., is based in Mesqu
• United Health Products Changes Principal Executive Offices — 8-K · Nov 6, 2024 Risk: low
  United Health Products, Inc. filed an 8-K on November 6, 2024, reporting an event that occurred on November 4, 2024. The filing indicates the company's principa
• United Health Products Q2 2024: Assets Near Liabilities — 10-Q · Aug 13, 2024 Risk: medium
  United Health Products, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $248,233,222 and total liabilities of $244
• United Health Products Files S-1/A Amendment — S-1/A · Jul 25, 2024 Risk: medium
  United Health Products, Inc. filed an S-1/A amendment on July 25, 2024, for a registration statement under the Securities Act of 1933. The company, previously k
• United Health Products, Inc. Files S-1/A Amendment — S-1/A · Jul 22, 2024 Risk: medium
  United Health Products, Inc. filed an S-1/A amendment on July 22, 2024, to its registration statement. The company, previously known as United EcoEnergy Corp. a
• United Health Products Files S-1/A Amendment — S-1/A · Jul 15, 2024 Risk: medium
  United Health Products, Inc. filed an S-1/A amendment on July 15, 2024, to its registration statement. The company, previously known as United EcoEnergy Corp. a
• United Health Products Files S-1 for Potential Offering — S-1 · Jun 26, 2024 Risk: medium
  United Health Products, Inc. filed an S-1 form on June 26, 2024, indicating a potential offering of securities. The company, previously known as United EcoEnerg
• United Health Products Enters Material Definitive Agreement — 8-K · Jun 25, 2024 Risk: medium
  United Health Products, Inc. entered into a material definitive agreement on June 20, 2024. The filing does not disclose specific details of the agreement or an
• United Health Products, Inc. Files 10-Q for Q1 2024 — 10-Q · May 9, 2024 Risk: low
  United Health Products, Inc. (UEEC) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Filing is a 10-Q for the period ending March 31, 2024. Company
• United Health Products, Inc. Files 2023 Annual Report (10-K) — 10-K · Apr 1, 2024 Risk:
  United Health Products, Inc. (UEEC) filed a Annual Report (10-K) with the SEC on April 1, 2024. United Health Products, Inc. (UEEC) filed its 10-K for the fisca

Risk Profile

Risk Assessment: Of UEEC's 18 recent filings, 3 were flagged as high-risk, 10 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from United Health Products, INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $0
• Net Income: -$2,132,440
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $18,376
• Operating Margin: N/A
• Total Assets: $94,313
• Total Debt: $3,433,856

Key Executives

• Chief Executive Officer
• Douglas K. Beplate
• Brian Thom

Industry Context

The medical device industry, particularly for surgical products, is highly competitive and heavily regulated. Companies like UEEC must navigate complex approval processes (e.g., FDA Class III) and demonstrate clinical efficacy and safety to gain market traction. Success often hinges on innovation, strong clinical data, and effective sales and distribution channels.

Top Tags

sec-filing (5) · 10-K (3) · 10-Q (3) · amendment (3) · annual-report (2) · material-agreement (2) · Biotechnology (2) · Medical Devices (2) · Going Concern (2) · financials (2)

Key Numbers

• iXBRL 10-K Size: 976546 — Size of the main 10-K document in bytes.
• Complete Submission Text File Size: 4542022 — Size of the complete submission text file in bytes.
• Revenue: $0 — for the three and nine months ended September 30, 2025, indicating no sales
• Net Loss: $2,132,440 — for the nine months ended September 30, 2025, a 79.5% increase from prior year
• Cash and Cash Equivalents: $18,376 — as of September 30, 2025, down 89.1% from December 31, 2024
• Total Stockholders' Deficit: $3,339,543 — as of September 30, 2025, worsening from $2,443,831 at December 31, 2024
• Selling, General and Administrative Expenses: $1,768,183 — for the nine months ended September 30, 2025, a significant increase from $975,017 in 2024
• Net Loss (Six Months): $(1.85M) — Increased 108.9% from $(0.88M) in H1 2024 to $(1.85M) in H1 2025.
• SG&A Expenses (Six Months): $1.56M — Increased from $0.65M in H1 2024, contributing to wider net loss.
• Stockholders' Deficit: $(3.17M) — Deepened from $(2.44M) at Dec 31, 2024, reflecting accumulated losses.
• Common Shares Outstanding: 257,733,222 — As of August 14, 2025, indicating potential for further dilution.
• Total Liabilities: $3.25M — Increased from $2.71M at Dec 31, 2024, adding to financial strain.
• Total Assets: $300.0B — As of the reporting period end.
• Q1 2025 Revenue: $0.001 — Indicates minimal sales activity in the first quarter.
• Fiscal Year End: 1231 — Standard year-end closing date for financial reporting.

Related Companies

UECC

Frequently Asked Questions